Evaluating liver type fatty acid binding protein as a diagnostic and prognostic biomarker in metabolic dysfunction-associated steatotic liver disease in pediatric patients
L-FABP shows promise as a non-invasive biomarker for diagnosing and monitoring MASLD in pediatric patients. Its association with disease stages suggests its utility in assessing disease progression, particularly in advanced stages.
Authors
- Nadia Al Mazrouei (ORCID: https://orcid.org/0000-0002-1339-9730)
- Osama Mohamed Ibrahim (ORCID: https://orcid.org/0000-0002-2868-039X)
- Semira Abdi Beshir (ORCID: https://orcid.org/0000-0003-4990-4783)
- Ali Awadallah Saeed (ORCID: https://orcid.org/0000-0003-3524-4825)
- Asim Ahmed Elnour (ORCID: https://orcid.org/0000-0002-4143-7810)
- Sami Fatehi Abdalla (ORCID: https://orcid.org/0000-0002-7396-8376)
- Amal Ahmed Mohamed (ORCID: https://orcid.org/0000-0002-2014-2239)
- Marafi Jammaa Ahmed (ORCID: https://orcid.org/0009-0000-5032-8627)
- Vineetha Menon (ORCID: https://orcid.org/0000-0001-6916-5346)
- Mahitab Gamal
- Shaimaa Emad
- Mohamed Elgharbawy
- Heba Ali ElRamly
Institutions
- Alfaisal University (SA)
- Cairo University (EG)
- Al Ain University (AE)
- Gulf Medical University (AE)
- University of Sharjah (AE)
- National University (SD)
- National Water Research Center (EG)
- University of Bahri (SD)
- Dar Al Uloom University (SA)
- October 6 University (EG)
- Dubai Pharmacy College (AE)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-09-30
- DOI
- https://doi.org/10.1371/journal.pone.0333581
- Citations
- 2
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.71